CNS clinical trials : suicidality and data collection : workshop summary /
"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Washington, D.C. :
National Academies Press,
©2010.
|
Colección: | Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf. |
Temas: | |
Acceso en línea: | Texto completo |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | EBOOKCENTRAL_ocn709768285 | ||
003 | OCoLC | ||
005 | 20240329122006.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 110329s2010 dcua ob 100 0 eng d | ||
010 | |a 2012419234 | ||
040 | |a N$T |b eng |e pn |c N$T |d E7B |d YDXCP |d NATAP |d OCLCQ |d VT2 |d OCLCQ |d OCLCA |d OCLCF |d NLGGC |d OCLCO |d COF |d MMU |d CDX |d AU@ |d OCLCO |d EBLCP |d OCLCQ |d OCLCO |d OCL |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d AZK |d OCLCO |d OCLCQ |d AGLDB |d TOA |d OCLCO |d LIP |d PIFAG |d MERER |d ZCU |d MERUC |d OCLCQ |d NJR |d OCLCO |d U3W |d BUF |d OCLCO |d OCLCQ |d OCLCO |d CUY |d KIJ |d OCLCO |d OCLCQ |d STF |d WRM |d VNS |d OCLCQ |d VTS |d EZ9 |d OCLCQ |d ICG |d OCLCO |d OCLCQ |d OCLCO |d WYU |d OCLCA |d LVT |d OCLCA |d S9I |d TKN |d OCLCQ |d DKC |d OCLCO |d UUM |d OCLCQ |d M8D |d OCLCO |d UKAHL |d OCLCQ |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCA |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
016 | 7 | |a 101555848 |2 DNLM | |
019 | |a 701906352 |a 764551204 |a 842281300 |a 961490256 |a 962604355 |a 971092356 |a 990588620 |a 1021261898 |a 1028771577 |a 1048092812 |a 1055337414 |a 1058077483 |a 1061049063 |a 1061073294 |a 1063813209 |a 1119430850 |a 1119447786 |a 1119456427 |a 1119458535 |a 1156343889 |a 1204383941 |a 1204385559 |a 1228597279 |a 1229435819 |a 1249237913 | ||
020 | |a 9780309148849 |q (electronic bk.) | ||
020 | |a 0309148847 |q (electronic bk.) | ||
020 | |z 0309148839 | ||
020 | |z 9780309148832 | ||
029 | 1 | |a AU@ |b 000047057144 | |
029 | 1 | |a AU@ |b 000050896796 | |
029 | 1 | |a AU@ |b 000051319190 | |
029 | 1 | |a DEBBG |b BV043071518 | |
029 | 1 | |a DEBBG |b BV044109167 | |
029 | 1 | |a DEBSZ |b 421636173 | |
029 | 1 | |a NZ1 |b 13870278 | |
029 | 1 | |a AU@ |b 000075782263 | |
035 | |a (OCoLC)709768285 |z (OCoLC)701906352 |z (OCoLC)764551204 |z (OCoLC)842281300 |z (OCoLC)961490256 |z (OCoLC)962604355 |z (OCoLC)971092356 |z (OCoLC)990588620 |z (OCoLC)1021261898 |z (OCoLC)1028771577 |z (OCoLC)1048092812 |z (OCoLC)1055337414 |z (OCoLC)1058077483 |z (OCoLC)1061049063 |z (OCoLC)1061073294 |z (OCoLC)1063813209 |z (OCoLC)1119430850 |z (OCoLC)1119447786 |z (OCoLC)1119456427 |z (OCoLC)1119458535 |z (OCoLC)1156343889 |z (OCoLC)1204383941 |z (OCoLC)1204385559 |z (OCoLC)1228597279 |z (OCoLC)1229435819 |z (OCoLC)1249237913 | ||
043 | |a n-us--- | ||
050 | 4 | |a RC569 |b .C537 2010eb | |
060 | 4 | |a HV 6543 | |
072 | 7 | |a PSY |x 037000 |2 bisacsh | |
082 | 0 | 4 | |a 616.858445 |2 22 |
049 | |a UAMI | ||
245 | 0 | 0 | |a CNS clinical trials : |b suicidality and data collection : workshop summary / |c Sarah Hanson, Miriam Davis and Bruce Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
246 | 3 | |a Central nervous system clinical trials | |
260 | |a Washington, D.C. : |b National Academies Press, |c ©2010. | ||
300 | |a 1 online resource (xii, 75 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file |2 rda | ||
504 | |a Includes bibliographical references (pages 43-49). | ||
505 | 0 | |a Perspectives from the FDA, academia, and patients -- Data collection and optimization -- Data analysis -- Partnerships, opportunities, collaboration. | |
520 | |a "The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description. | ||
588 | 0 | |a Print version record. | |
546 | |a English. | ||
590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
650 | 0 | |a Suicide |z United States |x Prevention |v Congresses. | |
650 | 0 | |a Suicidal behavior |z United States |v Congresses. | |
650 | 0 | |a Clinical health psychology |z United States |v Congresses. | |
650 | 0 | |a Clinical trials |z United States |v Congresses. | |
650 | 0 | |a Nervous system |v Congresses. | |
650 | 0 | |a Suicide |x Prevention. | |
650 | 0 | |a Mental illness. | |
650 | 2 | |a Suicide Prevention | |
650 | 2 | |a Mental Disorders | |
650 | 6 | |a Suicide |z États-Unis |x Prévention |v Congrès. | |
650 | 6 | |a Comportement suicidaire |z États-Unis |v Congrès. | |
650 | 6 | |a Santé |x Psychologie clinique |z États-Unis |v Congrès. | |
650 | 6 | |a Études cliniques |z États-Unis |v Congrès. | |
650 | 6 | |a Système nerveux |v Congrès. | |
650 | 6 | |a Suicide |x Prévention. | |
650 | 6 | |a Maladies mentales. | |
650 | 7 | |a mental disorders. |2 aat | |
650 | 7 | |a PSYCHOLOGY |x Suicide. |2 bisacsh | |
650 | 7 | |a Mental illness |2 fast | |
650 | 7 | |a Clinical health psychology |2 fast | |
650 | 7 | |a Clinical trials |2 fast | |
650 | 7 | |a Nervous system |2 fast | |
650 | 7 | |a Suicidal behavior |2 fast | |
650 | 7 | |a Suicide |x Prevention |2 fast | |
651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
655 | 2 | |a Congress | |
655 | 7 | |a proceedings (reports) |2 aat | |
655 | 7 | |a Conference papers and proceedings |2 fast | |
655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
655 | 7 | |a Actes de congrès. |2 rvmgf | |
700 | 1 | |a Hanson, Sarah L. |q (Sarah Lynn), |d 1980- |1 https://id.oclc.org/worldcat/entity/E39PCjtMKMRmr337YhpGHTRkDq | |
700 | 1 | |a Davis, Miriam |c (Medical writer) |1 https://id.oclc.org/worldcat/entity/E39PCjG4jMPrtykHbyc3wdkGgX | |
700 | 1 | |a Altevogt, Bruce M. | |
710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Neuroscience and Nervous System Disorders. | |
758 | |i has work: |a CNS clinical trials (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGpc7KFYQmcvxw9JBHHqHC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |t CNS clinical trials. |d Washington, D.C. : National Academies Press, ©2010 |z 9780309148832 |w (OCoLC)655759716 |
830 | 0 | |a Online access: National Academy of Sciences National Academies Press. | |
830 | 0 | |a Online access: NCBI NCBI Bookshelf. | |
856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378727 |z Texto completo |
938 | |a Askews and Holts Library Services |b ASKH |n AH36617295 | ||
938 | |a Askews and Holts Library Services |b ASKH |n AH36559193 | ||
938 | |a Coutts Information Services |b COUT |n 17275943 | ||
938 | |a EBL - Ebook Library |b EBLB |n EBL3378727 | ||
938 | |a ebrary |b EBRY |n ebr10443269 | ||
938 | |a EBSCOhost |b EBSC |n 354528 | ||
938 | |a YBP Library Services |b YANK |n 3753761 | ||
994 | |a 92 |b IZTAP |